Institute for Stem Cell Biology and Regenerative Medicine (InStem) is inviting applications for a Postdoctoral Position in Bioengineering of 3D skeletal muscle organoids for understanding the metabolic basis of myogenesis, and response to injury (Advt No.16/2019).
About the project:
- Project Title- Bioengineering of 3D skeletal muscle organoids for understanding the metabolic basis of myogenesis, and response to injury.
- The position is available in the Ramanathan group.
- Candidate will have the opportunity to develop cutting edge technologies using 3D tissue printing for modeling tissue injury.
- This is a unique opportunity to lead and build a 3D organoid platform that has broad institute-wide interest and translational opportunities.
- The Ramanathan group is situated in the Bangalore Life Science cluster, with world-class facilities in 3D printing, tissue culture, microscopy and relevant analytical platforms.
- The project will be focused on building mammalian skeletal muscle tissue using 3D bioprinting of primary mammalian myoblasts.
- The Bioengineered tissues will enable the understanding of the metabolic basis of myoblast fusion and membrane dynamics, during myogenesis and injury.
- The organoids will be studied using live cell imaging, immunostaining and metabolic profiling.
Requirements:
- Candidate must hold B.Tech, Masters or PhD degree with experience or interest in bioengineering, 3D bioprinting and muscle biology.
- Knowledge of CAD or other 3D software such as Autodesk- Fusion 360 for designing of 3D scaffolds would be preferred.
Applications:
Send application to 3dprintinginstem@gmail.com including: CV, cover letter describing research background and a list of three individual references.
—————–Quick Overview————- | |
Organization | Institute for Stem Cell Biology and Regenerative Medicine (InStem) |
Country | India |
Fellowship Level | Postdoctoral |
Subject areas | Bioengineering, 3D Bioprinting, Muscle Biology |
Fellowship amount | Varies |
Eligibility | Open to Indian nationals |
Deadline | 31 December 2019 |
———————————— |